Fingerprint
Dive into the research topics of 'Switching from subcutaneous to intravenous erythropoietin alpha in haemodialysis patients requires a major dose increase'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Switching from subcutaneous to intravenous erythropoietin alpha in haemodialysis patients requires a major dose increase
Jack W Galliford, Rao Malasana, Ken Farrington
Research output: Contribution to journal › Article › peer-review
11
Citations
(Scopus)